BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25130393)

  • 1. Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapy.
    Ischia J; Patel O; Sethi K; Nordlund MS; Bolton D; Shulkes A; Baldwin GS
    BJU Int; 2015 May; 115(5):829-38. PubMed ID: 25130393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal fragments of the gastrin-releasing peptide precursor stimulate cell proliferation via a novel receptor.
    Patel O; Dumesny C; Shulkes A; Baldwin GS
    Endocrinology; 2007 Mar; 148(3):1330-9. PubMed ID: 17122080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
    Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
    Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of gastrin-releasing peptide (GRP) in normal and cancerous urological tissues.
    Ischia J; Patel O; Bolton D; Shulkes A; Baldwin GS
    BJU Int; 2014 Mar; 113 Suppl 2():40-7. PubMed ID: 24894852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).
    Dumesny C; Patel O; Lachal S; Giraud AS; Baldwin GS; Shulkes A
    Endocrinology; 2006 Jan; 147(1):502-9. PubMed ID: 16223866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney.
    Dumesny C; Whitley JC; Baldwin GS; Giraud AS; Shulkes A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F578-85. PubMed ID: 15140764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma.
    Pansky A; DE Weerth A; Fasler-Kan E; Boulay JL; Schulz M; Ketterer S; Selck C; Beglinger C; VON Schrenck T; Hildebrand P
    J Am Soc Nephrol; 2000 Aug; 11(8):1409-1418. PubMed ID: 10906154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide: different forms, different functions.
    Ischia J; Patel O; Shulkes A; Baldwin GS
    Biofactors; 2009; 35(1):69-75. PubMed ID: 19319848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
    Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
    Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo.
    Patel O; Clyde D; Chang M; Nordlund MS; Steel R; Kemp BE; Pritchard DM; Shulkes A; Baldwin GS
    Endocrinology; 2012 Mar; 153(3):1082-92. PubMed ID: 22202166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
    Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
    Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive.
    Patel O; Dumesny C; Shulkes A; Baldwin GS
    Cancer Lett; 2007 Aug; 254(1):87-93. PubMed ID: 17395367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: biological implications.
    Baldwin GS; Patel O; Shulkes A
    Regul Pept; 2007 Oct; 143(1-3):1-14. PubMed ID: 17395282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
    Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
    J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraintestinal roles of bombesin-like peptides and their receptors: lung.
    Qin XQ; Qu X
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):22-6. PubMed ID: 23222852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.